In recent years, advances in the treatment and management of patients with systemic lupus
erythematosus (SLE) have improved their life expectancy and quality of life. However, lupus …

В настоящее время получены веские доказательства фундаментальной роли
патологической активации В-клеток в патогенезе иммуновоспалительных …

Системная красная волчанка (СКВ)-системное аутоиммунное ревматическое
заболевание неизвестной этиологии, характеризующееся гиперпродукцией …

Autoimmune diseases refer to a group of conditions where the immune system produces an
immune response against self-antigens, resulting in tissue damage. These diseases have …

The pharmacological treatment of systemic lupus erythematosus (SLE) aims to decrease
disease activity, progression, systemic compromise, and mortality. Among the …

We aimed to evaluate the clinical outcome of Systemic Autoimmune Diseases (SADs)
patients hospitalized with COVID-19 in Spain, before the introduction of SARS-CoV-2 …

Objectives: To analyze the characteristics and the predictive factors of the use of rituximab
and belimumab in daily practice in patients from the inception cohort Registro Español de …

Owing to its systemic nature with multiple organs potentially being affected concurrently or
sequentially and at varying degrees of severity, the management of systemic lupus …

Objectives We have reported previously that Belimumab, a human monoclonal antibody that
inhibits B-cell activating factor (BAFF) could be an effective and safe option to treat …

Иммуновоспалительные (аутоиммунные и аутовоспалительные) ревматические
заболевания-не только весьма распространенные и тяжелые хронические …